U.S. Other Utilities Stock News

If you are wondering whether DigitalBridge Group is still attractively priced after its recent run, looking closely at its valuation metrics can help you decide what the current share price really offers. The stock last closed at US$15.41, with returns of 0.0% over 7 days, 0.4% over 30 days, 0.2% year to date, 43.9% over 1 year, 13.5% over 3 years, and a 36.3% decline over 5 years. Taken together, these figures give a mixed picture of how the market has treated the shares over different...

Mirum Pharmaceuticals: Stock Moves and Business Snapshot Mirum Pharmaceuticals (MIRM) has seen its share price move recently, and investors are revisiting the biopharma name with its focus on rare and orphan liver diseases and a growing commercial portfolio. See our latest analysis for Mirum Pharmaceuticals. The recent 2.2% 1 day share price return, 15.4% 30 day share price return and very large 5 year total shareholder return suggest momentum has been building for Mirum, as investors react...

Earnings, AI launch, and bond deals put T-Mobile US (TMUS) in focus T-Mobile US (TMUS) is back in the spotlight after unveiling a real-time agentic AI platform inside its network, pairing that launch with fresh 2025 results, 2026 guidance, and multi tranche euro bond offerings. See our latest analysis for T-Mobile US. The share price has been strong in the near term, with a 14.45% 1 month share price return and a 6.85% year to date share price return, while the 1 year total shareholder return...

BrightSpring Health Services (NasdaqGS:BTSG) has been added to several S&P indices, including the S&P SmallCap 600 and S&P Composite 1500. The index changes highlight growing attention from institutional investors toward the company. Recent contract wins for high margin specialty drugs serving complex conditions are supporting business momentum. BrightSpring operates in healthcare services and specialty pharmaceuticals, areas that sit at the intersection of aging demographics, chronic...

If you are wondering whether Universal Health Services is still reasonably priced after its recent run, this article is going to focus squarely on what you are paying for compared to what you are getting. The stock last closed at US$235.29, with returns of 1.7% over 7 days, 17.7% over 30 days, 7.0% year to date, 28.8% over 1 year, 61.9% over 3 years, and 75.1% over 5 years. This performance has many investors reassessing the balance between potential growth and risk. Recent coverage has...

LegalZoom.com (LZ) heads into its upcoming earnings report with revenue guidance for the next quarter above analyst forecasts and a beat on current quarter revenue estimates, catching investor attention around expectations and execution. See our latest analysis for LegalZoom.com. At a share price of $6.97, LegalZoom.com has seen a 1-month share price return of a 21.42% decline and a year-to-date share price return of a 27.32% decline. The 1-year total shareholder return of a 22.98% decline...

What MetLife’s Recent Share Performance Tells Investors MetLife (MET) has quietly moved higher in recent weeks, with the share price up around 4.8% over the past month and 5.5% over the past 3 months, drawing fresh attention from income and value focused investors. See our latest analysis for MetLife. Set against a small year to date share price return decline of 1.4% and a 1 year total shareholder return decline of 1.4%, the recent 30 and 90 day share price gains suggest momentum has picked...

If you are wondering whether AAR's current share price lines up with its underlying worth, this article will walk through what the numbers are actually saying about value. AAR's stock last closed at US$114.63, with returns of 0.9% over the past 7 days, 9.1% over 30 days, 35.7% year to date, 78.3% over 1 year, 112.5% over 3 years, and 168.0% over 5 years, which may influence how much upside or downside you feel is left. Recent news coverage around AAR has largely focused on its role in the...

BlackRock, ticker NYSE:BLK, is moving ahead with its Ethereum ETF, ETHB, which is structured to pass staking rewards through to fund investors. The product is described as a first of its kind in the US market for giving ETF holders direct exposure to Ethereum staking economics. Institutional investors including Harvard Management Company and Abu Dhabi's Mubadala are reported to be shifting allocations from Bitcoin ETFs into BlackRock's Ethereum offerings. BlackRock, ticker NYSE:BLK, is...

In recent months, LKQ has faced sector pressure following weak earnings from competitor Genuine Parts Company, alongside lowered 2025 guidance, a Board-led strategic review that could include a sale, and ongoing patent litigation with General Motors. At the same time, institutional investors such as Kiltearn Partners and Aristotle Capital Boston have been building positions in LKQ, reflecting interest in its scale, logistics investments, and role in alternative collision repair parts...

Red Cat Holdings (RCAT) is back in focus after new drone orders from Asia Pacific allies, deeper work in autonomous reconnaissance systems, a higher weighting in a defense ETF, and easing short interest reshaped recent sentiment around the stock. See our latest analysis for Red Cat Holdings. Those new orders and ETF inflows arrive as the share price sits at $12.08, with a 1 day share price return of 5.96% and a 90 day share price return of 96.74%. The 3 year total shareholder return is very...

T1 Energy Inc. disclosed that the employment of Denise Cruz, Senior Vice President, Chief Accounting Officer and Corporate Controller, was terminated effective immediately on February 5, 2026, and that Tom Mahrer, a veteran finance leader with extensive SEC reporting and energy-sector experience, was appointed to those roles the same day. Mahrer’s background across Valero, KPMG, and Deloitte, combined with his recent role leading T1’s SEC reporting, places a technically focused insider at...

If you are wondering whether Interactive Brokers Group is priced attractively today, this article will walk through what the current share price could mean for long term investors. The stock recently closed at US$74.90, with returns of a 1.9% decline over 7 days, 2.1% over 30 days, 11.4% year to date and 29.5% over the past year, while the three year return is around 3.5x and the five year return is just over 4x. Recent headlines around Interactive Brokers Group have focused on its position...

Hershey stock snapshot after recent performance shift Hershey (HSY) has quietly put in a strong stretch, with the share price up about 12% over the past month and roughly 22% in the past 3 months, drawing fresh attention from investors. See our latest analysis for Hershey. Set against a 1-year total shareholder return of 39.63% and a 5-year total shareholder return of 69.68%, the recent 21.73% year to date share price return suggests momentum has been building again despite some short term...

NCR Atleos recently expanded access for UnionPay cardholders, allowing them to withdraw cash at up to 13,000 Cashzone ATMs across the UK, many located in high-traffic and tourist areas. This collaboration underscores NCR Atleos’ role in cross-border cash access and tourism-related payments, reinforcing its position in self-directed banking infrastructure. We’ll now explore how this wider UnionPay access across Cashzone ATMs could influence NCR Atleos’ investment narrative and long-term cash...

Ally Financial (ALLY) is back in focus after its latest results showed year-over-year net income of US$300 million and a resumed US$2b share buyback, even as credit costs and margin pressures keep investors cautious. See our latest analysis for Ally Financial. The latest earnings and buyback news comes after a mixed stretch for the stock, with a 12.1% 90 day share price return but an 8.0% year to date share price decline. The 3 year total shareholder return of 55.5% suggests longer term...

FirstEnergy FY 2025 Earnings Snapshot FirstEnergy (FE) just posted its latest FY 2025 numbers with Q3 revenue of US$4.1 billion and basic EPS of US$0.76, setting a clear marker for how the year is shaping up. The company has seen revenue move from US$3.0 billion in Q4 2024 to US$3.4 billion in Q2 2025 and US$4.1 billion in Q3 2025, while quarterly EPS ranged from US$0.45 to US$0.76 over the same stretch, and trailing twelve month EPS sits at US$2.31 on revenue of US$14.3 billion. With net...

In February 2026, Mirion Technologies reported full-year 2025 revenue of US$925.4 million and net income of US$28.8 million, issued guidance for approximately low-twenties percentage revenue growth in 2026, announced record annual orders above US$1 billion, and reshaped its leadership team with new nuclear, nuclear medicine, and AI-focused roles. By elevating nuclear power and nuclear medicine leadership and appointing a Chief Artificial Intelligence & Digital Officer, Mirion is explicitly...

Board transition and recent earnings context IDEXX Laboratories (IDXX) is in focus after reporting fourth quarter results that exceeded analyst expectations on both revenue and earnings per share, along with 2026 guidance that some analysts view with caution. At the same time, the company outlined plans for around 5,500 new InVueDx system placements in 2026 to help address pressure from fewer pet visits, giving investors a concrete operational metric to track. See our latest analysis for...

If you have ever wondered whether Berkshire Hathaway is fairly priced or offering hidden value right now, you are not alone. This article is built to help you frame that question clearly. The stock last closed at US$499.07, with returns of 0.4% year to date, 3.2% over 1 year, 64.6% over 3 years and 100.9% over 5 years, while the 7 day return sits at a 0.2% decline. Recent coverage has focused on Berkshire's role as a diversified holding company, its large portfolio of listed equities and its...

UBS reiterated its positive view on Veracyte (VCYT) after the company’s fourth quarter testing revenue topped expectations, highlighting higher average selling prices and prior period collections as key drivers, rather than underlying test volume trends. See our latest analysis for Veracyte. Veracyte’s share price has softened recently, with a 30-day share price return of an 11.93% decline and a year-to-date share price return of a 13.64% decline. This comes even though the three-year total...

In its fourth-quarter 2025 investor letter, Gator Capital Management disclosed that it had purchased a position in TFS Financial Corporation in December, citing the bank’s mutual holding company structure and the benefit of lower short-term interest rates. Gator Capital Management highlighted that this structure, combined with what it views as an underappreciated earnings recovery potential, could create an attractive, asymmetric risk/reward profile for public shareholders. With these...

Waystar Holding FY 2025 Earnings Snapshot Waystar Holding (WAY) has wrapped up FY 2025 with fourth quarter revenue of US$303.5 million and basic EPS of US$0.10, alongside net income of US$20.0 million. Over the last six reported quarters, the company has seen revenue move from US$240.1 million in Q3 2024 to US$303.5 million in Q4 2025. Quarterly basic EPS shifted from US$0.03 in Q3 2024 to a trailing twelve month EPS of US$0.63 by Q4 2025, supported by trailing twelve month net income of...

Select Water Solutions (WTTR) has wrapped up FY 2025 with fourth quarter revenue of $346.5 million and a small net loss of $0.3 million, which translated into roughly flat EPS at $0.00. Across the year, the company has seen quarterly revenue move between $322.2 million and $374.4 million, with EPS ranging from a high of $0.10 in Q2 to losses in both Q4 2025 and Q4 2024, setting up a mixed picture on earnings momentum. See our full analysis for Select Water Solutions. With the headline numbers...